Status:
COMPLETED
Heparin Induced Thrombocytopenia: Pharmacoeconomics
Lead Sponsor:
Brigham and Women's Hospital
Collaborating Sponsors:
Sanofi
Conditions:
Heparin Induced Thrombocytopenia (HIT)
Eligibility:
All Genders
Brief Summary
Patients at BWH receiving unfractionated heparin or enoxaparin who subsequently develop heparin induced thrombocytopenia will be identified via a computer generated report designed for the purposes of...
Detailed Description
The goal of this research is to investigate the outcomes and pharmacoeconomics of patients diagnosed with heparin induced thrombocytopenia (HIT). Background: Heparin induced thrombocytopenia (HIT) i...
Eligibility Criteria
Inclusion
- All patients hospitalized at BWH who have a PF4-Positive antibody test
Exclusion
Key Trial Info
Start Date :
July 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2009
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00456001
Start Date
July 1 2006
End Date
January 1 2009
Last Update
March 2 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115